- Conditions
- Immunization; Infection|Transplantation Infection|Influenza, Influenza
- Interventions
- Fluzone High Dose Inactivated Influenza Vaccine, Fluzone Standard Dose Inactivated Influenza Vaccine
- Biological
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–11
of 11
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Influenza, Orthomyxovirus Infection, Myxovirus Infection
- Interventions
- Influenza Virus Vaccine USP Trivalent Types A and B
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 807 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 28
- States / cities
- Hoover, Alabama • Mobile, Alabama • Chandler, Arizona + 24 more
- Conditions
- Influenza
- Interventions
- Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified), VCIV manufactured with the current manufacturing process (VCIV current), Fluzone®, licensed trivalent influenza vaccine (TIV)
- Biological
- Lead sponsor
- Alachua Government Services, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,928 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 20
- States / cities
- Chandler, Arizona • Anaheim, California • Paramount, California + 17 more
- Conditions
- Influenza
- Interventions
- Split, Inactivated, Trivalent Influenza vaccine (Fluzone®)
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia
- Conditions
- Influenza, Myxovirus Infection
- Interventions
- Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1), Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 2), Split, Inactivated, Trivalent Influenza Vaccine (Standard dose), Split, Inactivated, Trivalent Influenza Vaccine (High-dose)
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,098 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 29
- States / cities
- Alabaster, Alabama • Mobile, Alabama • Chandler, Arizona + 26 more
- Conditions
- Orthomyxoviridae Infection, Influenza, Myxovirus Infection
- Interventions
- Split, Inactivated, Trivalent Influenza Vaccine
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 817 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 17
- States / cities
- Alabaster, Alabama • Tucson, Arizona • Fountain Valley, California + 14 more
- Conditions
- Orthomyxoviridae Infection, Influenza, Myxovirus Infection
- Interventions
- Influenza Virus Vaccine USP Trivalent Types A and B
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 4,292 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 46
- States / cities
- Hoover, Alabama • Huntsville, Alabama • Mobile, Alabama + 40 more
- Conditions
- Influenza
- Interventions
- Fluzone® (IM), Fluzone®
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 217 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Atopic Dermatitis
- Interventions
- Fluzone® Intradermal (Sanofi Pasteur Inc.)
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Influenza, Orthomyxoviruses, Myxovirus Infection
- Interventions
- Influenza virus vaccine - cell-based (2007-2008 Formulation), Influenza virus vaccine (2007-2008 Formulation)
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 729 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 15
- States / cities
- Hoover, Alabama • Mobile, Alabama • Tucson, Arizona + 12 more
- Conditions
- Orthomyxoviridae Infection, Influenza, Myxovirus Infection
- Interventions
- Split, Inactivated, Trivalent Influenza Vaccine, Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 6 Months to 8 Years
- Enrollment
- 520 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 19
- States / cities
- Harrisburg, Arkansas • Little Rock, Arkansas • Trumann, Arkansas + 15 more